Whereas, ICQA showed dramatically protective effect on liver fibrosis via inhibiting the up-regulated expression of hepatic α-SMA and dose-dependently suppressing the hepatic Hyp as well as the serum fibrosis markers (Table 2 and Figure 3). Here, ACTA1 is linked to Hepatic fibrosis.